October 14, 2025

Large cohort study links allergic rhinitis to higher risk of vision-threatening optic neuritis

October 14, 2025 / Research update / InnovateMed Author / optic neuritis

by Justin Jackson, Phys.org edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain Sungkyunkwan University researchers in Korea ran a nationwide cohort analysis linking allergic diseases to increased optic neuritis risk, with allergic rhinitis showing the strongest association. Optic neuritis is described as an autoimmune-mediated inflammatory demyelinating disorder that causes acute or subacute […]

Large cohort study links allergic rhinitis to higher risk of vision-threatening optic neuritis Read More »

Study finds hidden blood mutations spark obesity, diabetes and liver disease

October 14, 2025 / Research update / InnovateMed Author / liver disease

by Leah Buletti, University of Florida edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Experimental Dnmt3a-CH promotes obesity, impaired glucose metabolism, inflammation, and severe steatohepatitis. Credit: Journal of Clinical Investigation (2025). DOI: 10.1172/jci197100 UF Health Cancer Center researchers have found a surprising culprit behind common health problems such as obesity, diabetes and fatty liver disease: silent genetic glitches

Study finds hidden blood mutations spark obesity, diabetes and liver disease Read More »

New brain-scanning method could help improve how anxiety is understood and diagnosed

October 14, 2025 / Research update / InnovateMed Author / anxiety

by University of Portsmouth edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes University of Portsmouth PhD student Benjamin Stocker setting up the EEG system on a participant. Credit: University of Portsmouth A study by the University of Portsmouth in England has mapped the biological journey of anxiety in the brain when people are faced with a

New brain-scanning method could help improve how anxiety is understood and diagnosed Read More »

Common heart medication shows promise against liver cancer

October 14, 2025 / Research update / InnovateMed Author / liver cancer

by University of Mississippi edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Liver cancer is the third-leading cause of cancer deaths worldwide, but a new study shows the solution to targeting this difficult-to-treat disease may already exist. Yatendra Singh, a postdoctoral researcher in the University of Mississippi Department of Biology, found that

Common heart medication shows promise against liver cancer Read More »

Heart rate changes predict depression treatment success with magnetic brain stimulation, scientists discover

October 14, 2025 / Research update / InnovateMed Author / heart rate

by Genomic Press edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain Researchers led by Dr. Roberto Goya-Maldonado at the University Medical Center Göttingen have identified a rapid physiological marker that predicts which patients with major depression will respond to magnetic brain stimulation therapy. The article, published in Brain Medicine, found that patients

Heart rate changes predict depression treatment success with magnetic brain stimulation, scientists discover Read More »

Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis

October 14, 2025 / Research update / InnovateMed Author / multiple sclerosis

by Rae Lynn Mitchell, Texas A&M University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Journal of Neuroimmunology (2025). DOI: 10.1016/j.jneuroim.2025.578698 About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of remission. “Progressive MS is profoundly challenging because

Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis Read More »

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

October 14, 2025 / Clinical Practice / InnovateMed Author / psychiatric order

by Genomic Press edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Psychedelics activate the 5-HT2A receptor, upregulate brain-derived neurotrophic factor, and enhance synaptic plasticity, leading to therapeutic potential for stress and psychiatric disorders. Credit: Xiaohui Wang A peer-reviewed viewpoint article published in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders Read More »

Survey shows only 36% of neurologists identify motor deficits as part of autism diagnosis

October 14, 2025 / Clinical Practice / InnovateMed Author / autism

by University of California, Los Angeles edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Brett Sayles from Pexels A new UCLA Health study highlights concerning gaps in how child neurologists understand and address motor difficulties in children with autism, despite research showing these movement problems affect the majority of autistic children and can significantly impact their development.

Survey shows only 36% of neurologists identify motor deficits as part of autism diagnosis Read More »

Incisionless brain surgery procedure has rejuvenated over 700 lives

October 14, 2025 / Research update / InnovateMed Author / incisionless brain surgery

by Chase Jordan edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain After having her head shaved by nurses at Novant Health Mint Hill Medical Center, patient Catherine Klie’s right hand shook as she tried to trace spiral circles and straight lines with a marker. It didn’t look good, with scribbly markings

Incisionless brain surgery procedure has rejuvenated over 700 lives Read More »

250-year-old drug enters clinical trial as potential treatment for deadly pancreatic cancer

October 14, 2025 / Research update / InnovateMed Author / pancreatic cancer

by University of Skövde edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world’s deadliest cancers. A heart medicine first prescribed in the 18th century is now being tested as a potential treatment for pancreatic cancer—one of the most aggressive and

250-year-old drug enters clinical trial as potential treatment for deadly pancreatic cancer Read More »